Diabetes Canada Podcast – Détails, épisodes et analyse

When you live with diabetes, your treatment plan may need the occasional change. However, in some cases that doesn’t happen. That might be because of an issue known as “clinical or therapeutic inertia”. Dr. Peter Senior, Director of the Alberta Diabetes Institute, joins host Krista Lamb to discuss what this is and why it matters.

In Canada, leading stem cell scientists are working hard to find ways to use these cells to improve the health of people living with type 1 diabetes.

On this episode, host Krista Lamb speaks with Dr. Francis Lynn from the BC Children’s Hospital Research Institute. Dr. Lynn is leading research projects using stem-cell-derived beta cells, as well as exploring ways to use CRISPR technology in this work.

He is also the winner of the 2021 Early Career Researcher Partnership Award from Diabetes Canada.

Did you know that people with type 2 diabetes are more likely to develop osteoarthritis than those without diabetes? This fact has inspired researchers like Dr. Gillian Hawker to look at ways to better support those managing both of these chronic conditions.

Dr. Hawker is a Professor of Medicine at the University of Toronto, where she is the Sir John & Lady Eaton Professor & Chair of the Department of Medicine. She is also a Clinician-Scientist at the Women’s College Research Institute.

A number of scientists around the world are researching brown adipose tissue to determine the role this brown fat plays in type 2 diabetes.

On this episode, host Krista Lamb speaks with Dr. Andre Carpentier, who is a clinician scientist at Sherbrook University and the Co-Scientific Lead at Diabetes Action Canada.

Dr. Carpentier is giving a sneak peek of his talk from the Diabetes Canada/CSEM Professional Conference and Annual General Meetings, which are taking place in Calgary, Alberta from November 9 – 12, 2022 in Calgary, Alberta. Interested in learning more or registering to attend in-person or virtually? Visit dcanconference.ca for more information.